EcoDrugPlus

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSDCDG00000005473
Gene Symbol: GUCY1A1
3 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSDCDG00000030879
Gene Symbol: GUCY1A2
3 Cross references
204 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSDCDG00000005263
Gene Symbol: GUCY1B1
3 Cross references
211 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha

Ensembl ID : ENSDCDG00000026024
Gene Symbol: LOC114803107
3 Cross references
317 Possible Orthologues:

Heat Shock Protein Hsp 90-Beta

Ensembl ID : ENSDCDG00000008304
Gene Symbol: LOC114792954
3 Cross references
357 Possible Orthologues:

High Affinity Nerve Growth Factor Receptor-Like

Ensembl ID : ENSDCDG00000014373
Gene Symbol: LOC114790203
3 Cross references
200 Possible Orthologues:

High Mobility Group Box 1

Ensembl ID : ENSDCDG00000034077
Gene Symbol: HMGB1
3 Cross references
454 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSDCDG00000032177
Gene Symbol: LOC114769021
3 Cross references
510 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSDCDG00000035297
Gene Symbol: HRH1
3 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSDCDG00000001925
Gene Symbol: HRH2
1 Cross references
181 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSDCDG00000014511
Gene Symbol: HRH2A
1 Cross references
192 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSDCDG00000030880
Gene Symbol: HDAC1
3 Cross references
257 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).